Theravance Biopharma, Inc. (FRA:0TB)

Germany · Delayed Price · Currency is EUR

17.10

+0.10 (0.59%)

At close: Nov 28, 2025

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Human Therapeutics	64.38M	Log In	Log In	Log In	Log In	Upgrade
Human Therapeutics Growth	12.12%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
United States	64.38M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	12.55%	Log In	Log In	Log In	Log In	Upgrade
Europe	-	Log In	Log In	Log In	Log In	Upgrade
Europe Growth	-	Log In	Log In	Log In	Log In	Upgrade